It has been found that the functional dynamics of IL6 might be crucial for the outcome of etanercept therapy and the particular role of IL6 in RA is presently considered in therapeutic interventions that target IL6 or its receptor [13]. The gene discussed is IL6; the disease is rheumatoid arthritis.